等待开盘 07-02 09:30:00 美东时间
-3.400
-1.75%
BWX Technologies (NYSE:BWXT) has outperformed the market over the past 5 years by 15.39% on an annualized basis producing an average annual return of 26.89%. Currently, BWX Technologies has a market capitalization of $17.52 billion. Buying $1000 In BWXT: If an investor had bought $1000 of BWXT stock...
今天 04:30
今日重点评级关注:Baird:维持Regenxbio"跑赢大市"评级,目标价从27美元升至32美元;古根海姆:维持Tenax Therapeutics"买入"评级,目标价从34美元升至40美元
06-23 13:48
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Roth Capital analyst Leo Mariani upgraded APA Corp (NASDAQ:APA) from Neutral to Buy and raised th...
06-22 20:31
Seaport Global analyst Jeff Campbell upgrades BWX Technologies (NYSE:BWXT) from Neutral to Buy and announces $245 price target.
06-22 20:28
Fusion energy has long been the technology of the future. The U.S. Department of Energy just put a target date on when it wants that future to arrive. The DOE on Tuesday released its finalized Fusion Science and Technology Roadmap, outlining a national strategy aimed at supporting fusion pilot plant...
06-10 20:40
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从11美元升至12美元;Ladenburg Thalmann:维持Usio"买入"评级,目标价从5.75美元升至6.25美元
05-18 11:48
Deutsche Bank analyst Scott Deuschle upgrades BWX Technologies (NYSE:BWXT) from Hold to Buy and raises the price target from $205 to $255.
05-15 18:04
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
BWX Technologies, Inc. (NYSE:BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling more than $1.4 billion.The first contract, valued at $1.285 billion, supports long-lead material
05-07 20:14
华盛资讯5月5日讯,BWX Technologies, Inc.公布2026财年Q1业绩,公司Q1营收8.60亿美元,同比增长26.1%,归母净利润0.91亿美元,同比增长20.7%。
05-05 12:47